Optical Systems for in Vivo Molecular Imaging of Cancer

Author:

Sokolov Konstantin1,Aaron Jesse2,Hsu Betsy2,Nida Dawn2,Gillenwater Ann3,Follen Michele4,MacAulay Calum5,Adler-Storthz Karen6,Korgel Brian7,Descour Michael8,Pasqualini Renata9,Arap Wadih9,Lam Wan10,Richards-Kortum Rebecca2

Affiliation:

1. Department of Imaging Physics, The University of Texas MD Anderson Cancer Center Houston, TX 77030

2. Department of Biomedical Engineering, The University of Texas at Austin Austin, TX 78712

3. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center Houston, TX 77030

4. Dept. of Gynecologic Oncology & Center for Biomedical Engineering, The University of Texas MD Anderson Cancer Center Houston, TX 77030

5. Department of Cancer Imaging, British Columbia Cancer Agency Vancouver, British Columbia

6. Department of Diagnostic Sciences The University of Texas Health Science Center at Houston Dental Branch Houston, TX 77030

7. Department of Chemical Engineering The University of Texas at Austin Austin, TX 78712

8. Optical Sciences Center The University of Arizona Tucson, AZ 85724

9. Depts. of Medicine and Cancer Biology The University of Texas MD Anderson Cancer Center Houston, TX 77030

10. Dept. of Cancer Genetics & Devel. Bio. British Columbia Cancer Agency Vancouver, British Columbia

Abstract

Progress toward a molecular characterization of cancer would have important clinical benefits; thus, there is an important need to image the molecular features of cancer in vivo. In this paper, we describe a comprehensive strategy to develop inexpensive, rugged and portable optical imaging systems for molecular imaging of cancer, which couples the development of optically active contrast agents with advances in functional genomics of cancer. We describe initial results obtained using optically active contrast agents to image the expression of three well known molecular signatures of neoplasia: including over expression of the epidermal growth factor receptor (EGFR), matrix metallo-proteases (MMPs), and oncoproteins associated with human papillomavirus (HPV) infection. At the same time, we are developing inexpensive, portable optical systems to image the morphologic and molecular signatures of neoplasia noninvasively in real time. These real-time, portable, inexpensive systems can provide tools to characterize the molecular features of cancer in vivo.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology

Cited by 182 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Nanobiotechnology for Cancer Diagnosis;Interdisciplinary Biotechnological Advances;2024

2. Orbital Angular Momentum Based Sensing and Their Applications: A Review;Journal of Lightwave Technology;2023-04-01

3. Bioconjugates: Preparation methods and therapeutic applications;Bioconjugated Materials Part 1 Preparation, Characterization and Applications in Therapeutics, Environmental monitoring and Point-of-care diagnostics;2023

4. Gold nanoparticle-based aptasensors: A promising perspective for early-stage detection of cancer biomarkers;Materials Today Communications;2022-03

5. Nanoparticle Based CT Contrast Agents;Harnessing Materials for X-ray Based Cancer Therapy and Imaging;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3